Expanding Support for Living Donors Act of 2026
HB7868, titled the Expanding Support for Living Donors Act of 2026, would amend the Public Health Service Act’s Living Organ Donation Reimbursement Program to broaden and standardize reimbursement support for living organ donors. The bill would prohibit grant recipients from using household income as a basis to deny reimbursement eligibility for donors whose household income is at or below 700 percent of the federal poverty line. It also sets a reimbursement cap of $10,000 for fiscal year 2027, with annual inflation adjustments in later years, while allowing the Secretary of Health and Human Services to lower that cap if a grant recipient lacks sufficient funds, subject to advance notice to Congress.
The bill further extends and expands the program’s authorization of appropriations from a fixed $5 million annual authorization for fiscal years 2005 through 2009 to whatever sums are necessary for fiscal years 2028 through 2037. It requires annual public reporting beginning in fiscal year 2027 on funding adequacy, participation, demographics, expenses, program impacts, administrative costs, and estimated Medicare savings. It also directs the Comptroller General to study whether Medicare could, under existing authority, pay costs that would otherwise be covered by the reimbursement program and to recommend any needed statutory changes.
The bill’s impact on state laws is minimal to none, because it amends federal public health law and governs a federal grant reimbursement program. Its practical effect would be on the administration of living organ donation reimbursements, the eligibility of donors for expense coverage, the amount of reimbursement available, and the reporting obligations of HHS and grant recipients. It could also influence transplant-related financing and donor participation nationwide, including how expenses tied to kidney or other living organ donations are reimbursed.
The general sentiment reflected by the bill’s structure is supportive of living organ donation and reducing financial barriers for donors. Although there are no committee transcripts or recorded votes in the provided material, the bill’s sponsors and provisions suggest a pro-donor, access-expanding approach focused on making reimbursement more available and transparent. The inclusion of reporting requirements and a GAO study also indicates an interest in measuring program effectiveness and exploring whether Medicare could shoulder some costs.
The main points of contention are likely to involve cost, eligibility thresholds, and program administration. The 700 percent of poverty line income threshold may draw scrutiny from those concerned about the scope of eligibility, while the inflation-adjusted reimbursement cap and the Secretary’s authority to lower it for insufficient funds could raise concerns about whether donors will actually be made whole. Another likely issue is whether federal reimbursement should be expanded further through Medicare or other mechanisms, and whether the program’s long-term funding needs are sustainable.
The bill amends section 377 of the Public Health Service Act, expanding the federal Living Organ Donation Reimbursement Program by setting a new income-based eligibility rule, establishing a $10,000 reimbursement cap for fiscal year 2027 with inflation indexing thereafter, and extending the program’s authorization of appropriations through fiscal year 2037. It also imposes detailed annual reporting requirements on the Secretary of Health and Human Services and directs a GAO study on whether Medicare could lawfully cover costs now paid through the program. The bill does not directly alter state statutes, but it would affect federal grant recipients, transplant donors, and the administration of living organ donation reimbursement nationwide.
The available material suggests broadly favorable sentiment toward the bill’s goal of supporting living organ donors and reducing financial disincentives to donation. The measure is framed as an expansion of assistance and transparency, with no recorded opposition or vote history provided. Its emphasis on reimbursement, reporting, and a Medicare study indicates a policy approach aimed at strengthening the program rather than limiting it.
Likely areas of contention include the cost of expanding reimbursements, the adequacy of the $10,000 cap, and whether the 700 percent of poverty line eligibility threshold is too broad or too narrow. Some may question the Secretary’s authority to reduce the cap when funds are insufficient, since that could leave donors partially reimbursed. Others may debate the feasibility and desirability of shifting some costs to Medicare, as well as whether the program should be expanded further or instead targeted more narrowly to preserve funding.